Bottom line
LHCAX vs GGHCX: the short answer
LHCAX (Lord Abbett Health Care Fund) and GGHCX (INVESCO Health Care Fund) are both mutual funds.
LHCAX is cheaper at 1.03% vs 1.07% — a difference of $4.00 a year per $10,000 invested.
Over five years, LHCAX returned +3.1% a year vs +2.6% for GGHCX.
Updated Nov 19, 2026
LHCAX vs GGHCX side by side
| LHCAX | GGHCX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Lord Abbett | Invesco |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.03% | 1.07% |
| Annual cost per $10k | $103 | $107 |
| 10-yr cost on $10k (prospectus) | $3,961 | $1,784 |
| Max front load | 5.75% | 5.5% |
| 12b-1 fee | 0.25% | 0.25% |
| 1-yr return | +10.9% | +9.2% |
| 5-yr return (annualized) | +3.1% | +2.6% |
| 10-yr return (annualized) | — | +5.8% |
| Best quarter | +21.5% | +19.6% |
| Worst quarter | −11.4% | −16.5% |
| Net assets (fund) | $8.6M | $1.2B |
| Number of holdings | 61 | 82 |
| Portfolio turnover | 91% | 59% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | LHCAX | GGHCX | Difference |
|---|---|---|---|
| 2025 | +17.7% | +15.5% | +2.2% |
| 2024 | +7.3% | +4.0% | +3.3% |
| 2023 | +2.9% | +3.1% | −0.1% |
| 2022 | −12.0% | −13.5% | +1.5% |
| 2021 | +8.2% | +12.2% | −3.9% |
| 2020 | +37.1% | +14.5% | +22.7% |
Source: Fund prospectus bar charts
Holdings overlap
10 of LHCAX's top 25 holdings also appear in GGHCX's top 25.
| Holding | LHCAX | GGHCX |
|---|---|---|
| Eli Lilly & Co | 10.40% | 10.59% |
| UnitedHealth Group Inc | 5.39% | 6.17% |
| Johnson & Johnson | 4.96% | 6.76% |
| Gilead Sciences Inc | 3.53% | 3.63% |
| CVS Health Corp | 3.33% | 2.52% |
| Guardant Health Inc | 2.61% | 2.04% |
| Thermo Fisher Scientific Inc | 2.31% | 1.55% |
| Vertex Pharmaceuticals Inc | 2.24% | 2.01% |
| Bridgebio Pharma Inc | 1.84% | 1.43% |
| Edwards Lifesciences Corp | 1.78% | 1.56% |
Source: SEC Form N-PORT
LHCAX top 10
- Eli Lilly & Co — 10.40%
- UnitedHealth Group Inc — 5.39%
- Johnson & Johnson — 4.96%
- Novartis AG — 4.19%
- Natera Inc — 3.60%
- Gilead Sciences Inc — 3.53%
- CVS Health Corp — 3.33%
- Guardant Health Inc — 2.61%
- Galderma Group AG — 2.60%
- Thermo Fisher Scientific Inc — 2.31%
GGHCX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
FAQ
What is the difference between LHCAX and GGHCX?
Which is cheaper, LHCAX or GGHCX?
Should I own both LHCAX and GGHCX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.